Healthcare Experience

Brand Institute Healthcare Share of Market


Our Healthcare experience includes 590 clients, with 2,277 partnered brands and 445 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
RADIUS HEALTH abaloparatide women's health
RAPTOR PHARMACEUTICALS PROCYSBI * Immunology
RAPTOR PHARMACEUTICALS QUINSAIR Antibiotic
REATA PHARMACEUTICALS omaveloxolone Ophthalmology
REATA PHARMACEUTICALS AIM - ANTIOXIDANT INFLAMMATION MODULATOR Class Name
REATA PHARMACEUTICALS bardoxolone methyl Cardiovascular
RECEPTOS ozanimod Immunology
RECKITT BENCKISER MUCINEX * Respiratory
RECKITT BENCKISER MUCINEX WITH CODEINE Respiratory
REGENERON PHARMACEUTICALS EYLEA Ophthalmology
REGENERON PHARMACEUTICALS ZALTRAP Oncology
REGENERX ARISE Clinical Trial Name
REGENERX SEER Clinical Trial Name
RELIANT PHARMACEUTICALS INNOPRAN XL Cardiovascular
RELIANT PHARMACEUTICALS LOVAZA Cardiovascular
RELIANT PHARMACEUTICALS RYTHMOL SR Cardiovascular
RELYPSA VELTASSA * Hematology
RELYPSA patiromer sorbitex calcium Nephrology
RENAISSANCE PHARMA PRESTIUM PHARMA Corporate Identity
RENESSEN XENGROW AG Veterinary
REPLIDYNE bederocin Antibiotic
RESEARCH TO PRACTICE RESEARCH TO PRACTICE Corporate Identity
RESONANTSENSORS RESO VU Medical Device
RESONANTSENSORS BIONETIC Medical Device
RESONANTSENSORS RESOSENS Medical Device
RESONANTSENSORS RESONANTSENSORS.COM Website
RESVERLOGIX apabetalone Cardiovascular
RHODES PHARMACEUTICALS APTENSIO XR * Neurology
RIEMSER ALVALIN Obesity
ROCHE GAZYVA * Oncology
ROCHE KADCYLA (カドサイラ) Oncology
ROCHE imgatuzumab Oncology
ROCHE CINTEC HISTOLOGY Medical Device
ROCHE CINTEC CYTOLOGY Medical Device
ROCHE ALENEPHRO Clinical Trial Name
ROCHE BONIVA * Endocrinology
ROCHE COPEGUS Antiviral
ROCHE MIRCERA Hematology
ROCHE palovarotene Respiratory
ROCHE ROACTEMRA * Immunology
ROCHE TARCEVA * Oncology
ROCHE XELODA Oncology
ROCHE XENICAL Obesity
ROCHE XUBIX Cardiovascular
ROCHE ACTEMRA * Immunology
ROCHE ALECARDIO Clinical Trial Name
ROCHE CERA - CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR Class Name
ROCHE T-EMERGE Clinical Trial Name
ROCHE taspoglutide Endocrinology
ROCHE ALEPREVENT Clinical Trial Name
ROCHE ESBRIET Respiratory
ROCHE ALECENSARO * Oncology
ROXRO PHARMA SPRIX Pain & Inflammation


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMA, and/or Health Canada, and other Regulatory Agencies.

Back to top